378 related articles for article (PubMed ID: 34426962)
1. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.
Agrawal A; Narayan G; Gogoi R; Thummer RP
Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962
[TBL] [Abstract][Full Text] [Related]
2. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG
Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255
[TBL] [Abstract][Full Text] [Related]
4. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
5. Applications of iPSC-derived beta cells from patients with diabetes.
Maxwell KG; Millman JR
Cell Rep Med; 2021 Apr; 2(4):100238. PubMed ID: 33948571
[TBL] [Abstract][Full Text] [Related]
6. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.
Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H
Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313
[TBL] [Abstract][Full Text] [Related]
7. Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control.
Kim MJ; Lee EY; You YH; Yang HK; Yoon KH; Kim JW
Stem Cell Res; 2020 Oct; 48():101958. PubMed ID: 32882526
[TBL] [Abstract][Full Text] [Related]
8. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
[TBL] [Abstract][Full Text] [Related]
9. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols.
Liew CG
Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967
[TBL] [Abstract][Full Text] [Related]
10. iPSC technology-based regenerative therapy for diabetes.
Kondo Y; Toyoda T; Inagaki N; Osafune K
J Diabetes Investig; 2018 Mar; 9(2):234-243. PubMed ID: 28609558
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
12. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
Bose B; Katikireddy KR; Shenoy PS
Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
[TBL] [Abstract][Full Text] [Related]
13. microRNA-690 regulates induced pluripotent stem cells (iPSCs) differentiation into insulin-producing cells by targeting Sox9.
Xu Y; Huang Y; Guo Y; Xiong Y; Zhu S; Xu L; Lu J; Li X; Wan J; Lu Y; Wang Z
Stem Cell Res Ther; 2019 Feb; 10(1):59. PubMed ID: 30767782
[TBL] [Abstract][Full Text] [Related]
14. Generation of Pancreatic β-cells From iPSCs and their Potential for Type 1 Diabetes Mellitus Replacement Therapy and Modelling.
Csobonyeiova M; Polak S; Danisovic L
Exp Clin Endocrinol Diabetes; 2020 May; 128(5):339-346. PubMed ID: 30114722
[TBL] [Abstract][Full Text] [Related]
15. Gene-edited human stem cell-derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice.
Maxwell KG; Augsornworawat P; Velazco-Cruz L; Kim MH; Asada R; Hogrebe NJ; Morikawa S; Urano F; Millman JR
Sci Transl Med; 2020 Apr; 12(540):. PubMed ID: 32321868
[TBL] [Abstract][Full Text] [Related]
16. Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells.
Manzar GS; Kim EM; Zavazava N
J Biol Chem; 2017 Aug; 292(34):14066-14079. PubMed ID: 28360105
[TBL] [Abstract][Full Text] [Related]
17. Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo.
Pellegrini S; Ungaro F; Mercalli A; Melzi R; Sebastiani G; Dotta F; Broccoli V; Piemonti L; Sordi V
Acta Diabetol; 2015 Dec; 52(6):1025-35. PubMed ID: 25733399
[TBL] [Abstract][Full Text] [Related]
18. Distinctive Clinical and Pathologic Features of Immature Teratomas Arising from Induced Pluripotent Stem Cell-Derived Beta Cell Injection in a Diabetes Patient.
Han L; He H; Yang Y; Meng Q; Ye F; Chen G; Zhang J
Stem Cells Dev; 2022 Mar; 31(5-6):97-101. PubMed ID: 35018826
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
[TBL] [Abstract][Full Text] [Related]
20. The progress of pluripotent stem cell-derived pancreatic β-cells regeneration for diabetic therapy.
Wang X; Gao M; Wang Y; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():927324. PubMed ID: 35966093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
